In our Ontario BC cohort, 14.3% of women diagnosed between 2012 and 2016 were categorized as having HER2+ breast cancer, in line with expected rates (15–20%) [1] and recent large population-based reports [17]. The gene discussed is ERBB2; the disease is breast cancer.